AMYL THERAPEUTICS
- Biotech or pharma, therapeutic R&D
Amyl Therapeutics is a preclinical-stage biotechnology company developing a unique, strongly differentiated technology, aiming at taking the treatment of neurodegenerative diseases to the next level. To this end, we require € 20M to develop our product up to clinical proof of concept of efficacy against Alzheimer’s disease in order to penetrate this 50 billion+ market and finally give to the patients and their caregivers the treatment they deserve.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}